Oral contraceptives in migraine therapy

被引:0
作者
Gianni Allais
Ilaria Castagnoli Gabellari
Cristina De Lorenzo
Ornella Mana
Chiara Benedetto
机构
[1] University of Turin,Department of Gynecology and Obstetrics, Women’s Headache Center
来源
Neurological Sciences | 2011年 / 32卷
关键词
Combined oral contraceptives; Headache; Hormonal treatment; Migraine; Oral contraceptive- induced menstrual migraine; Progestogen-only pill;
D O I
暂无
中图分类号
学科分类号
摘要
Even if sometimes combined oral contraceptives (COCs) can initiate or aggravate headaches, in particular migraine, the headaches generally tend to improve after the first months of COC use. If migraine persists, in many patients the attacks are more likely to occur during the pill-free week, and an oral contraceptive-induced menstrual migraine (OCMM) occurs. In case of OCMM, some hormonal manipulations are available, by eliminating or reducing the hormone-free interval (HFI), in order to prevent this estrogen-withdrawal headache. It is possible to use a continuous COCs regimen, to shorten the HFI to less than the traditional 7 days, to use a low-dose estrogen supplementation after the 21 days of COCs or to prescribe a progestogen–only pill (POP). Interestingly, the use of a POP is a safe option also for women suffering from migraine with aura (in which COCs are absolutely contraindicated) and a recent trial suggests that its use can reduce the frequency of migraine attacks and the duration of aura symptoms too.
引用
收藏
页码:135 / 139
页数:4
相关论文
共 50 条
[21]   Combined hormonal contraceptives and migraine: An update on the evidence [J].
Calhoun, Anne H. ;
Batur, Pelin .
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2017, 84 (08) :631-638
[22]   Comparative cost-effectiveness analysis of oral triptan therapy for migraine in four European countries [J].
Hens, Manuel ;
Villaverde-Hueso, Ana ;
Alonso, Veronica ;
Abaitua, Ignacio ;
Posada de la Paz, Manuel .
EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2014, 15 (04) :433-437
[23]   Thrombotic risks of oral contraceptives [J].
Rott, Hannelore .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2012, 24 (04) :235-240
[24]   Light Therapy in Chronic Migraine [J].
Hou, Tsung-Wei ;
Yang, Cheng-Chia ;
Lai, Tzu-Hsien ;
Wu, Ying-Hui ;
Yang, Chun-Pai .
CURRENT PAIN AND HEADACHE REPORTS, 2024, 28 (07) :621-626
[25]   New Targets for Migraine Therapy [J].
Amy R. Tso ;
Peter J. Goadsby .
Current Treatment Options in Neurology, 2014, 16
[26]   New Targets for Migraine Therapy [J].
Tso, Amy R. ;
Goadsby, Peter J. .
CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2014, 16 (11)
[27]   Combined Hormonal Contraceptives: Is It Time to Reassess Their Role in Migraine? [J].
Calhoun, Anne .
HEADACHE, 2012, 52 (04) :648-660
[28]   Oral and Gut Dysbiosis in Migraine: Oral Microbial Signatures as Biomarkers of Migraine [J].
Cho, Soomi ;
Jung, Yeonjae ;
Oh, Hyun-Seok ;
Yum, Jungyon ;
Song, Seungwon ;
Jeong, Jaewook ;
Ha, Woo-Seok ;
Kim, Kyung Min ;
Kim, Won-Joo ;
Chu, Min Kyung .
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2025, 12 (05)
[29]   Interplay of Oral, Mandibular, and Facial Disorders and Migraine [J].
Teruel, Antonia ;
Romero-Reyes, Marcela .
CURRENT PAIN AND HEADACHE REPORTS, 2022, 26 (07) :517-523
[30]   Oral Triptans and Nausea: Treatment Considerations in Migraine [J].
Pierce, Mark .
HEADACHE, 2013, 53 :17-20